| Literature DB >> 24265730 |
Dimitrios Paraskevis1, Georgios Nikolopoulos, Anastasios Fotiou, Chrissa Tsiara, Dimitra Paraskeva, Vana Sypsa, Marios Lazanas, Panagiotis Gargalianos, Mina Psichogiou, Athanasios Skoutelis, Lucas Wiessing, Samuel R Friedman, Don C D E S Jarlais, Manina Terzidou, Jenny Kremastinou, Meni Malliori, Angelos Hatzakis.
Abstract
BACKGROUND: During 2011, a dramatic increase (1600%) of reported HIV-1 infections among injecting drug users (IDUs) was noted in Athens, Greece. We herein assess the potential causal pathways associated with this outbreak.Entities:
Mesh:
Year: 2013 PMID: 24265730 PMCID: PMC3827120 DOI: 10.1371/journal.pone.0078941
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Number of reported HIV-1 cases among injecting drug users (IDUs) (blue) and the total population (red) over different years.
Figure 2a Sentinel anti-HIV prevalence in IDUs entering drug treatment or accessing low-threshold services during the years 2002–2012 in Athens and areas other than Athens. b Sentinel anti-HCV prevalence in injecting drug users (IDUs) entering drug-related treatment or accessing low-threshold services during 2002–2012 in Athens and areas other than Athens. c Sentinel anti-HCV prevalence in IDUs with injecting history of less than 2 years (“new” IDUs) entering drug-related treatment or accessing low-threshold services during 2002–2012 in Athens and areas other than Athens. d Unemployment and homelessness rate drug injectors during 2002–2011 in Athens. Data were not collected in 2007.
Prevalence of HIV-1 subtypes and recombinant forms.
| Subtypes (n, %)Populations | A | CRF35_AD | B | CRF14_BG | CRF02_AG | Others | Total | |
| Total sampled HIV-1 infected population (1998–2009) | 572 (24.6%) | 0 | 1,396 (60.0%) | 0 | 44 (1.9%) | 315 (13.5%) | 2,327 | |
| IDUs (1998–2009) | 22 (28.9%) | 0 | 43 (56.6%) | 0 | 4 (5.3%) | 7 (9.2%) | 76 |
|
| IDUs (2010–2012) | 23 (11.2%) | 58 (28.2%) | 41 (19.9%) | 75 (36.4%) | 1 (0.5%) | 8 (3.9%) | 206 |
|
IDUs: Injecting Drug Users; CRF: Circulating Recombinant Forms (CRFs).
Comparison of the prevalence of subtypes and CRFs between the total sampled HIV-1 infected population (1998–2009) and the IDUs (1998–2009).
Comparison of the prevalence of subtypes and CRFs between the IDUs sampled during 1998–2009 and 2010–2012.
Patterns of HIV-1 spread in IDUs.
| HIV spread (n,%) Populations | Clustered HIV-1 infections | Non-clustered HIV-1 infections | Total | |
|
| 4 (5.3%) | 72 (94.7%) | 76 | |
|
| 5 (41.3%) | 7 (58.3%) | 12 |
|
|
| 106 (94.6%) | 6 (5.4%) | 112 |
|
|
| 76 (92.7%) | 6 (7.3%) | 82 |
|
IDUs: Injecting Drug Users.
Comparisons of each group with the IDUs samples during 1998–2009.
Characteristics of phylogenetic clusters among injecting drug users (IDUs).
| IDU phylogeneticcluster | IDUs percluster (N0) | Samplingperiod | Geographicalorigin | Nationality ofpotential founder | tMRCA(95% HPD) | |
| ID | Clade | |||||
| 1 | CRF14_BG | 75 | 2010–2012 | W.Europe | Bulgaria | 2009 (2008–2010) |
| 2 | CRF35_AD | 58 | 2011–2012 | Afghanistan-Iran | Iran | 2009 (2007–2011) |
| 3 | B | 34 | 2011–2012 | Greece | Greece | 2008 (2003–2010) |
| 4 | A | 12 | 2011–2012 | Greece | Greece | 2010 (2009–2011) |
| 5 | AFSU | 2 | 2010 | FSU | NA | 2008 (2005–2010) |
| 6 | CRF02_AG | 2 | 2005 and 2010 | NA | NA | 2005 (2003–2005) |
| 7 | B | 2 | 2002 and 2010 | NA | NA | 1996 (1986–2001) |
| 8 | B | 2 | 2002 and 2003 | NA | NA | 1985 (1972–1995) |
FSU: Former Soviet Union.
tMRCA: Time to most recent common ancestor.
HPD: Higher Posterior Density.
NA: Not Available.
Figure 3Molecular clock analyses of HIV-1 sequences from: A. subtype A and CRF35_AD B. subtype B and C. subtype G and CRF14_BG sampled from different geographic areas and Greece.
Figure 4Plot of the reporting rate of HIV-1 infection among injecting drug users (IDUs) per 100,000 of population in relation with the annual growth rate of gross domestic product (GDP).
IDU clusters are shown by triangles proportional to the number of sequences. The time to most recent common ancestor (tMRCA) for the different outbreaks is denoted at the top of each triangle. The tMRCA for both subtype B clusters 1 and 2 was estimated before 2002 not shown in figure.
Univariable ecological associations between the annual growth rate of Gross Domestic Product (GDP) in Greece and various dependent variables for the period 2001–2012.
| Dependent variable | Model | Coefficient | 95% CI | P-value |
| Reporting rate of HIV-1 infection in drug injectors | Negative binomialregression | 0.78 | (0.71, 0.85) | <0.001 |
| Prevalence of HIV-1 infection | Linear regression | −0.16 | (−0.32, 0.00) | 0.05 |
| Prevalence of HCV infection (antibodies) among drug injectors in Athens | Linear regression | −0.82 | (−1.47, −0.17) | 0.02 |
| Prevalence of HCV infection (antibodies) among new drug injectors in Athens | Linear regression | −3.33 | (−4.93, −1.73) | <0.001 |
| Homelessness rate among drug injectors in Athens | Linear regression | −1.73 | (−2.87, −0.59) | 0.01 |
| Unemployment rate among drug injectors in Athens | Linear regression | −0.97 | (−1.53, −0.41) | 0.01 |
CI: Confidence Interval, HIV: Human Immunodeficiency Virus, HCV: Hepatitis C VirusIn all models, robust estimates of variance have been used.
For the negative binomial regression model, the coefficient has been exponentiated corresponding to the reporting rate ratio of HIV-1 infection in drug injectors for one unit increase in the annual growth rate of GDP [i.e. for 1% increase of GDP each year, the reporting rate of HIV-1 infection in drug injectors reduces by 1–0.78 = 0.22 or 22%).
The prevalence of HIV-1 infection has been logged (natural logarithm).
Estimated among drug injectors who accessed drug treatment -or low-threshold services in Athens. Data were not available for 2001 and 2007.
“New” drug injectors: IDUs with injecting history of less than 2 years.
Estimated among drug injectors who contacted treatment services or low-threshold facilities in Athens. Data for 2007 and 2012 were not available.
Figure 5Working hypothesis for the HIV-1 outbreak in Athens Metropolitan Area.
Bold arrows indicate causal pathways suggested in the current study. Thin arrows indicate other possible causal pathways.